Browsing Tag
Philippe Calais
1 post
RNAZ stock surges as TransCode Therapeutics buys Polynoma and wins $25m CK Life Sciences funding for metastatic cancer pipeline
Find out how TransCode Therapeutics’ $25M CK Life Sciences funding and Polynoma buyout could redefine RNAZ’s role in cancer immunotherapy.